Clearwater Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
1,102
+18
+2% +$18.2K 0.08% 72
2025
Q4
$1.16M Sell
1,084
-61
-5% -$58.3K 0.1% 69
2025
Q3
$874K Buy
1,145
+11
+1% +$8.19K 0.07% 87
2025
Q2
$884K Buy
1,134
+6
+0.5% +$4.66K 0.08% 81
2025
Q1
$932K Sell
1,128
-8
-0.7% -$6.66K 0.09% 79
2024
Q4
$877K Hold
1,136
0.09% 82
2024
Q3
$1.01M Buy
1,136
+91
+9% +$81.8K 0.1% 76
2024
Q2
$946K Sell
1,045
-120
-10% -$96K 0.1% 73
2024
Q1
$906K Sell
1,165
-37
-3% -$26.3K 0.1% 71
2023
Q4
$701K Buy
1,202
+15
+1% +$8.76K 0.08% 78
2023
Q3
$638K Sell
1,187
-60
-5% -$30.9K 0.08% 71
2023
Q2
$585K Buy
1,247
+10
+0.8% +$4.19K 0.07% 83
2023
Q1
$425K Sell
1,237
-264
-18% -$89K 0.05% 97
2022
Q4
$549K Buy
1,501
+52
+4% +$18.4K 0.07% 90
2022
Q3
$469K Buy
1,449
+20
+1% +$6.34K 0.06% 96
2022
Q2
$463K Hold
1,429
0.06% 96
2022
Q1
$409K Sell
1,429
-7
-0.5% -$1.8K 0.05% 112
2021
Q4
$397K Buy
1,436
+111
+8% +$28.1K 0.04% 117
2021
Q3
$306K Hold
1,325
0.04% 131
2021
Q2
$304K Hold
1,325
0.04% 135
2021
Q1
$248K Hold
1,325
0.03% 146
2020
Q4
$224K Buy
+1,325
New +$198K 0.03% 143
2018
Q2
Sell
-30
Closed -$2K 397
2018
Q1
$2K Buy
+30
New +$2.42K ﹤0.01% 599

Other funds holding LLY

Clearwater Capital Advisors's LLY Position: Q1 2026 in Review

Clearwater Capital Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $18.2K and bringing the position to 1,102 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #72.

Clearwater Capital Advisors first reported a position in LLY in Q1 2018 and has held it in 23 quarters since. The position peaked at $1.16M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Clearwater Capital Advisors held 1,102 shares of Eli Lilly worth $1.01M as of Q1 2026.
  • Clearwater Capital Advisors bought 18 Eli Lilly shares in Q1 2026, an estimated $18.2K.
  • Eli Lilly made up 0.08% of Clearwater Capital Advisors's portfolio in Q1 2026, its #72 holding.
  • Clearwater Capital Advisors first reported a position in Eli Lilly in Q1 2018 and has held it in 23 quarters since.
  • Clearwater Capital Advisors's Eli Lilly position peaked at $1.16M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Clearwater Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.